【輸入品・未使用】Inflammatory Bowel Disease: Experience and Controversy

【中古】【輸入品・未使用】
Inflammatory Bowel Disease: Experience and Controversy
【メーカー名】
Springer
【メーカー型番】

【ブランド名】
Springer
【商品説明】
Inflammatory Bowel Disease: Experience and Controversy
当店では初期不良に限り、商品到着から7日間は返品を 受付けております。
こちらは海外販売用に買取り致しました未使用品です。
買取り致しました為、中古扱いとしております。
他モールとの併売品の為、完売の際はご連絡致しますのでご了承下さい。
速やかにご返金させて頂きます。
ご注文からお届けまで
1、ご注文⇒ご注文は24時間受け付けております。
2、注文確認⇒ご注文後、当店から注文確認メールを送信します。
3、配送⇒当店海外倉庫から取り寄せの場合は10～30日程度でのお届けとなります。
国内到着後、発送の際に通知にてご連絡致します。
国内倉庫からの場合は３～７日でのお届けとなります。
　※離島、北海道、九州、沖縄は遅れる場合がございます。予めご了承下さい。
お電話でのお問合せは少人数で運営の為受け付けておりませんので、メールにてお問合せお願い致します。
営業時間　月～金　10:00～17:00
お客様都合によるご注文後のキャンセル・返品は
お受けしておりませんのでご了承下さい。13287円【輸入品・未使用】Inflammatory Bowel Disease: Experience and Controversy本・雑誌・コミックその他Inflammatory Bowel Disease: Experience and Controversy | SpringerLink

Inflammatory Bowel Disease: Experience and Controversy


Inflammatory Bowel Disease: Experience and Controversy | SpringerLink


Inflammatory Bowel Disease: Experience and Controversy | SpringerLink


Medicina | Free Full-Text | Inflammatory Bowel Disease: Clinical


Targeting immune cell circuits and trafficking in inflammatory


IJMS | Free Full-Text | Inflammatory Bowel Disease Treatments and


JCM | Free Full-Text | Predictors and Early Markers of Response to


Inflammatory Bowel Disease | NEJM


Diseases | Free Full-Text | Thromboembolic Events in Patients with


Evolving knowledge and therapy of inflammatory bowel disease


IBD disease-modifying therapies: insights from emerging


Drug delivery strategies in the therapy of inflammatory bowel


Personalised medicine in Crohn's disease - The Lancet


JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease


IBD Journal | Crohn's & Colitis Foundation


Antibody signatures in inflammatory bowel disease: current


Targeting immune cell circuits and trafficking in inflammatory


The current state of the art for biological therapies and new


Biologics | Free Full-Text | Biological Treatments in Inflammatory


IJMS | Free Full-Text | Inflammatory Bowel Disease Treatments and


Lightning Learning: Inflammatory Bowel Disease — EM3


Drug delivery to the inflamed intestinal mucosa – targeting


New Research Reveals High Cost of Care for Inflammatory Bowel


Inflammatory Bowel Disease | NEJM


Current and emerging therapies for inflammatory bowel disease (IBD


Inflammatory Bowel Disease | NEJM


Frontiers | Molecular medicine-based IBD treatment strategies—we


Site-specific targeted drug delivery systems for the treatment of


Current Therapy in Inflammatory Bowel Disease: Why and How We Need


Discovery of small-molecule candidates against inflammatory bowel


Defining the Future of Inflammatory Bowel Disease Care: The


Drug delivery strategies in the therapy of inflammatory bowel


Novel Targeted Therapies for Inflammatory Bowel Disease: Trends in


Approved treatments for inflammatory bowel disease (IBD). All


Inflammatory Bowel Disease articles and careers information on


Advances in the Treatment of Inflammatory Bowel Disease: Focus on


Inflammatory bowel disease biomarkers - Liu - 2022 - Medicinal


POTENT NEW MECHANISM OF ACTION FOR TREATMENT OF INFLAMMATORY BOWEL


Integrating omics for a better understanding of Inflammatory Bowel


The Cost of Inflammatory Bowel Disease | Crohn's & Colitis Foundation